2024 annual financial data
Aclaris Therapeutics 2024 Operating margin
Direct answer
Operating margin was -758.18%.
Operating income was -141,932,000 USD and net income was -132,065,000 USD.
Operating cash flow was -20,075,000 USD.
Get free Aclaris Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 18,720,000 USD
- Operating income
- -141,932,000 USD
- Net income
- -132,065,000 USD
- Operating cash flow
- -20,075,000 USD